IMA-970A

N/A

Report date: 2024/12/25 20:00:50

Base Information

Drug NameIMA-970A
Drug Alias NameIMA 970 AHepaVac-101 vaccineCancer Vaccine - HEPAVACHepatocellular carcinoma vaccine - HapaVaCIMA-970A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumItalyGermany +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFondazione Irccs Istituto Nazionale Dei TumoriImmatics Biotechnologies GmbhCurevac Ag +[5] 
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute Naples
Inactive CompaniesCurevac AgImmatics Biotechnologies Gmbh
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A